DotBio is a biopharmaceutical company specialized in next-generation domain antibody therapies.
Location: United States, North Carolina, Weddington
Total raised: $5.6M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.08.2023 | - | $5.6M | Gaorong Ca... |
Mentions in press and media 5
| Date | Title | Description |
| 10.08.2023 | DotBio Raises USD 5.6M in Pre-A Financing | DotBio, a Singapore-based biopharmaceutical company advancing antibody therapeutic modalities to bring more effective therapies to patients, closed a USD 5.6m Pre-Series A financing round. The round was led by Proxima Ventures and Gaorong C... |
| 10.08.2023 | Deals in brief: Meatable secures USD 35 million in funding, nine new deals for Chinese companies, and more | Meatable raises USD 35 million in its latest funding round The Netherlands-based food tech company has raised USD 35 million in its latest funding round led by Agronomics. Other investors that participated in the round include Dutch impact ... |
| 08.08.2023 | Deals in brief: Disprz and DotBio secure new funding, South Korean giants back AI startup, and more | Disprz secures USD 30 million in Series C round The India-based enterprise software-as-a-service learning and skilling platform has secured USD 30 million in a Series C funding round led by Lumos Capital Group and 360 ONE Asset (IIFL). The ... |
| 09.11.2021 | CStone Pharmaceuticals and DotBio sign a global discovery collaboration and option agreement to expand emerging portfolio of next-generation innovative therapeutics | The two sides will jointly develop up to three preclinical first-in-class or best-in-class next-generation antibody therapies, for which CStone would lead the design of the target combination based on the intended mechanism of action and Do... |
| 10.03.2021 | Uni-Bio Science Group and DotBio Announce Partnership to Co-Develop multi-specific DotBodies for people with retinal diseases | HONG KONG SAR – EQS Newswire – 10 March 2021 – A fully integrated biopharmaceutical company — Uni-Bio Science Group Limited (the “Company”, together with its subsidiaries, the “Group”; Stock code: 00690.HK) is pleased to announce that the c... |